Skip to main content
Clinical Trials/NCT05391828
NCT05391828
Recruiting
N/A

Randomized Control Trial Comparing Zimmer Biomet Persona Medial Congruent Versus Posterior Stabilized Total Knee Arthroplasty for Treatment of Knee Arthritis Using the ROSA Knee System

NYU Langone Health1 site in 1 country200 target enrollmentSeptember 27, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Total Knee Arthroplasty
Sponsor
NYU Langone Health
Enrollment
200
Locations
1
Primary Endpoint
European Quality of Life Five Dimension (EQ-5D) Score
Status
Recruiting
Last Updated
9 months ago

Overview

Brief Summary

A randomized, controlled study comparing two total knee implant devices, Persona medial congruent (MC) vs posterior stabilized (PS). These surgeries will be performed using the ROSA robotic system. Patients will be followed up to 5 years.

Registry
clinicaltrials.gov
Start Date
September 27, 2023
End Date
December 1, 2026
Last Updated
9 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients ≥18 years of age
  • Patients scheduled an elective primary TKA for a diagnosis of osteoarthritis or inflammatory arthritis using the ROSA Knee System.
  • Patient is willing to cooperate and follow study protocol and visit schedule
  • Subject has access to a device is capable of pairing to the Apple Watch, supporting application updates and is compatible with the mymobility App.

Exclusion Criteria

  • Patient is pregnant
  • Patient is unable to provide written consent
  • Revision TKA
  • History of prior infection in the affected knee
  • History of prior open surgery with significant hardware in place on the affected knee (i.e. prior distal femur or proximal tibia fracture or osteotomy)
  • Preoperative diagnosis of post-traumatic arthritis, avascular necrosis, or fracture

Outcomes

Primary Outcomes

European Quality of Life Five Dimension (EQ-5D) Score

Time Frame: Year 20

The EQ-5D comprises five questions on mobility, self care, pain, usual activities, and psychological status with three possible answers for each item (1=no problem, 2=moderate problem, 3=severe problem. A summary index with a maximum score of 1 can be derived from these five dimensions by conversion with a table of scores. The maximum score of 1 indicates the best health state, by contrast with the scores of individual questions, where higher scores indicate more severe or frequent problems. In addition, there is a visual analogue scale (VAS) to indicate the general health status (0-100) with 100 indicating the best health status.

Forgotten Joint Score (FJS)

Time Frame: Year 20

FJS is a patient-reported outcome measure intended to determine a patient's ability to "forget" about their affected joint after surgery or treatment. FJS consists of 12 questions - the total score range is 0-100. The higher the score, the less the patient is aware of their affected joint when performing daily activities.

Knee Injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS, JR)

Time Frame: Year 20

KOOS, JR contains 7 items from the original KOOS survey. Items are coded from 0 to 4, none to extreme respectively. KOOS, JR is scored by summing the raw response (range 0-28) and then converting it to an interval score. The interval score ranges from 0 to 100 where 0 represents total knee disability and 100 represents perfect knee health.

Secondary Outcomes

  • Change in Average gait speed(Baseline, Year 2)
  • Change in Average daily flight count(Baseline, Year 2)
  • Change in Average daily step count(Baseline, Year 2)

Study Sites (1)

Loading locations...

Similar Trials